Summary
There is a basic distinction between declarative memories, which can be stated verbally, and non-declarative memory, such as how to ride a bicycle, which cannot be expressed in words. With age it is the performance of declarative memory, particularly episodic memory that requires recall of events placed in time, that declines. As memory is not a unitary phenomenon, it should be ideally monitored using a range of tests that reflect theoretical conceptions of the topic. If circumstances demand the use of a single test then a measure of episodic memory is suggested. When it proves only possible to use a rating scale it should be ensured that memory is distinguished from other aspects of cognition and that different types of memory are not confused. The tests used, and the form in which they are used, need to be chosen to be of appropriate difficulty for the sample studied. A major conclusion is that the selection of the measure of memory used in the study of a dietary intervention should never be routine. It is inevitable that the form of the test used will need to be chosen carefully for the population being studied.
Similar content being viewed by others
References
Baddeley A (1992) Working memory. Science 255:556–559
Baddeley A (2000) The episodic buffer: a new component of working memory? Trends Cogn Sci 4:417–423
Shallice T, Fletcher P, Frityh CD, Grasby P, Frackowiak RSJ, Dolan RJ (1994) Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 368:633–635
Lee ACH, Robbins TW, Graham KS, Owen AM (2002) Pray or Prey? Dissociation of semantic memory retrieval from episodic memory processes using positron emission tomography and a novel homophone task. Neuroimage 16:724–735
Grady CL, Craik FIM (2000) Changes in memory processing with age. Curr Opin Neurobiol 10:224–231
Balota DA, Dolan PO, Duchek JM (2000) Memory changes in healthy older adults. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 395–409
Anderson ND, Craik FIM (2000) Memory in the aging brain. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 411–425
Burke DM, MacKay DG, Worthley JS, Wade E (1991) On the tip-of-the-tongue: What causes word finding failures in young and older adults? J Mem Lang 30:542–579
Collie A, Maruff P (2000) The neuropsychology of preclinical Alzheimer’s disease and mild cognitive impairment. Neurosci Biobehav Rev 24:365–374
Nilsson LG (2003) Memory function in normal aging. Acta Neurol Scand 179 (Suppl):7–13
Park HL, O’Connell JE, Thomson RG (2003) A systematic review of cognitive decline in the general elderly population. Int J Ger Psychiatry 18:1121–1134
Brayne C, Huppert F, Paykel E, Gill C (1992) The Cambridge project for later life: design and preliminary results. Neuroepidemiol 11(Suppl 1):71–75
Lyketsos C, Chen L-S, Anthony J (1999) Cognitive decline in adulthood: an 11.5 year follow-up of the Baltimore epidemiology catchment area study. Am J Psychiat 156:58–65
Bischkopf J, Busse A, Angermeyer MC (2002) Mild cognitive impairment—a review of prevalence, incidence and outcome according to current approaches. Acta Psychiatr Scand 106:403–414
Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild cognitive impairment: clinical characterisation and outcome. Arch Neurol 56:303–308
Newman SK, Warrington EK, Kennedy AM, Rossor M (1994) The earliest cognitive change in a person with familial Alzheimer’s disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer’s disease confirmed at autopsy. J Neurol Neurosurg Psychiatry 57:967–972
Hodges JR (2000) Memory in the dementias. In: Tulving E, Craik FIM (eds) The Oxford Handbook of Memory. Oxford University Press, Oxford, pp 441–459
Lorentz WJ, Scanlan JM, Borson S (2002) Brief screening tests for dementia. Can J Psychiatry 47:723–733
Brodaty H, Pond D, Kemp NM, Luscombe G, Harding L, Berman K, Huppert FA (2002) The GPCOG: a new screening test for dementia designed for general practice. J Am Geriatr Soc 50:530–534
Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Feher EP, Mahurin RK, Doody RS, Cooke N, Sims J, Pirozzolo FJ (1992) Establishing the limits of the Mini-Mental State: Examination of sub-tests. Arch Neurol 49:87–92
Wind AW, Schellevis FG, Van Staveren G, Scholten RP, Jonker C, Van Eijk JTM (1997) Limitations of the mini-mental state examination for diagnosing dementia in general practice. Int J Geriatr Psychiatry 12:101–108
Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J Amer Geriatr Soc 23:433–441
Smith G, Della Sala S, Logie RH, Maylor EA (2000) Prospective and retrospective memory in normal ageing and dementia: a questionnaire study. Memory 8:311–321
Crawford JR, Smith G, Maylor EA, Della Sala S, Logie RH (2000) The prospective and retrospective memory questionnaire (PRMQ): normative data and later structure in a large non-clinical sample. Memory 11:261–275
Wechsler D (1997) Wechsler Memory Scale—3rd UK Edition. Psychological Corporation,New York
Taylor EM (1959) The appraisal of children with cerebral deficits. Harvard University Press, Cambridge, MA
Buschke H, Fuld PA (1974) Evaluating storage, retention and retrieval in disordered memory and learning. Neurology 11:1019–1025
O’Connell ME, Tuokko H (2002) The 12-item Buschke memory test: appropriate for use across levels of impairment. Appl Neuropsychol 9:226–233
Wood FB, Ebert V, Kinsbourne M (1982) The episodic-semantic memory distinction in memory and amnesia: clinical and experimental observations. In: Cermak L (ed) Memory and amnesia. Lawrence Erlbaum Associates, Hillsdale, NJ, pp 167–194
Greene JD, Hodges JR (1996) Identification of famous faces and famous names in early Alzheimer’s disease. Relationship to anterograde episodic and general semantic memory. Brain 119:111–128
Uttl B (2005) Measurement of Individual Differences. Psychol Sci 16:460–467
Uttl B (2005) Age-related changes in event-cued prospective memory proper. In: Ohta N, MacLeod CM (eds) Dynamic cognitive processes. Springer-Verlag, Tokyo, pp 273–303
Theisen ME, Rapport LJ, Axelrod BN, Brines DB (1998) Effects of practice in repeated administrations of the Wechsler Memory Scale Revised in normal adults. Assessment 5:85–92
Canizares S, Boget T, Salamero M, Rumia J, Elices E, Arroyo S (2000) Reliability and clinical usefulness of the short forms of the Wechsler memory scale (revised) in patients with epilepsy. Epilepsy Res 41:97–106
Delaney RC, Prevey ML, Cramer J, Mattson RH (1992) Test-retest comparability and control subject data for the Rey-Auditory Verbal Learning Test and Rey-Osterrieth/Taylor Complex Figures. Arch Clin Neuropsychol 7:523–528
La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ (1997) Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 65:20–29
Rey A (1964) L’examen clinique en psychologie. Presses Universitaires de France
Mitrushina M, Boone KB, Razani LJ, D’Elia LF (2005) Handbook of Normative Data for Neuropsychological Assessment. Oxford University Press, Oxford
Pepeu G, Pepeu IM, Amaducci L (1996) A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? Pharmacol Res 33:73–80
Nunzi MG, Milan F, Guidolin D, Toffano G (1987) Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine administration. Neurobiol Aging 8:501–510
Klinkhammer P, Szelies B, Heiss W (1990) Effect of phosphatidylserine on cerebral glucose metabolism in Alzheimer’s Disease. Dementia 1:197–201
Delwaide PJ, Gyselynck-Mambourg AM, Hurlet A, Ylieff MPJ (1986) Double-blind randomized controlled study of phosphatidylserine in demented subjects. Acta Neurol Scand 73:136–140
Palmieri G, Palmieri R, Inzoli MR, Agrati AM, Vargiu A (1987) Double-blind controlled trial of phosphatidylserine in subjects with senile mental deterioration. Clin Trials J 24:73–83
Villardita JC, Griolis S, Salmeri G, Nicoletti F, Pennisi G (1987) Multicentre clinical trial of brain phosphatidylserine in elderly subjects with mental deterioration. Clin Trials J 24:84–93
Engel RR, Satzger W, Gunther W, Kathmann N, Bove D, Gerke S, Munch U, Hippius H (1992) Double-blind cross-over study of phosphatidylserine vs. placebo in subjects with early cognitive deterioration of the Alzheimer type. Eur Neuropsychopharmacol 2:149–155
Crook T, Petrie W, Wells C, Massari DC (1992) Effects of phosphatidylserine in Alzheimer’s disease. Psychopharmacol Bull 28:61–66
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G (1993) Cognitive decline in the elderly: A double blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 5:123–133
Heiss WD, Kessler J, Mielke R, Szelies B, Herholz K (1994) Long-term effects of phosphatidylserine, pyritinol, and cognitive training in Alzheimer’s disease.A neuropsychological, EEG, and PET investigation. Heiss 5:88–98
Maggioni M, Picotti GB, Bondiolotti GP, Panerai A, Cenacchi T, Nobile P, Brambilla F (1990) Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand 81:265–270
Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari CD (1991) Effects of phosphatidylserine in age-associated memory impairment. Neurology 41:644–649
Jorissen BL, Brouns F, Van Boxtel MP, Ponds RW,Verhey FR, Jolles J, Riedel WJ (2001) The influence of soy-derived phosphatidylserine on cognition in age-associated memory impairment Nutr Neurosci 4:121–134
Benton D, Donohoe RT (2005) The influence of phosphatidylserine and carnitine on the mood and the cognitive functioning of those over fifty-five years of age (unpublished findings)
Crook T, Bartus RT, Ferris SH, Whitehouse P, Cohen GD, Geshon S (1986) Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change: report of a National Institute of Mental Health Work Group. Dev Neuropsychol 2:261–276
Schreiber S, Kampf-Sherf O, Gorfine M, Kelly D, Oppenheim Y, Lerer B (2000) An open trial of plant-source derived phosphatidylserine for treatment of age-related cognitive decline. Isr J Psychiatr Relat Sci 37:302–307
Ortega RM, Requejo AM, Andres P, Lopez-Sobaler AM, Quintas ME, Redondo MR, Navia B, Rivas T (1997) Dietary intake and cognitive function in a group of elderly people. Am J Clin Nutr 66:803–809
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM (2002) Dietary intake of antioxidants and risk of Alzheimer disease. J Am Med Ass 287:3223–3239
Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, Wilson RS, Scherr PA (2002) Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J Am Med Ass 287:3230–3237
Morris MC, Evans DA, Bienias JL, Tangney CC, Wilson RS (2002) Vitamin E and cognitive decline in older persons. Arch Neurol 59:1125–1132
Luchsinger JA, Tang MX, Shea S, Mayeux R (2003) Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60:203–208
Perrig WJ, Perrig P, Stahelin HB (1997) The relation between antioxidants and memory performance in the old and very old. J Amer Geriatr Soc 45:718–724
Perkins AJ, Hendrie HC, Callahan CM, Gao S, Unverzagt FW, Xu Y, Hall KS, Hui SL (1999) Association of antioxidants with memory in a multiethnic elderly sample using the Third National Health and Nutrition Examination Survey. Am J Epidemiol 150:37–44
Ortega RM, Requejo AM, Lopez-Sobaler AM, Andres P, Navia B, Perea JM, Robles F (2002) Cognitive function in elderly people is influenced by vitamin E status. J Nutr 132:2065–2068
Sram RJ, Binkova B, Topinka J, Kotesovec F, Fojtikova I, Hanel I, Klaschka J, Kocisova J, Prosek M, Machalek J (1993) Effect of antioxidant supplementation in an elderly population. Basic Life Sci 61:459–477
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ (1997) A controlled trial of selegiline, alphatocopherol, or both as treatment for Alzheimer’s disease. New Eng J Med 336:1216–1222
Smith A, Clark R, Nutt D, Haller J, Hayward SA, Perry K (1999) Anti-oxidant vitamins and mental performance of the elderly. Hum Psychopharm 14:459–471
Masaki KH, Losonczy KG, Izmirlian G, Foley DJ, Ross GW, Petrovitch H, Havlik R, White LR (2000) Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 28:1265–1272
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Benton, D., Kallus, K.W. & Schmitt, J.A.J. How should we measure nutrition-induced improvements in memory?. Eur J Nutr 44, 485–498 (2005). https://doi.org/10.1007/s00394-005-0583-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00394-005-0583-6